Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL
Status:
Completed
Trial end date:
2020-02-06
Target enrollment:
Participant gender:
Summary
a multicenter, double-blind, placebo-controlled study in patients with Sudden Sensorineural
Hearing Loss (SSHL). Patients will be treated with STR001 thermogel (STR001-IT) / STR001
tablets (STR001-ER) and corresponding Placebo on top of standard of care.